Point72 Asset Management, L.P.
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1603466
STAMFORD, CT
Position in MDGL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$118,047,719
+$44,419,562 QoQ
Shares Held
225,510
+78.4% QoQ
Ownership
0.978%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
12 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Derivatives in MDGL
reported options exposure · as of Mar 31, 2026CallValue
$2,565,003
CallShares
4,900
PutValue
$2,355,615
PutShares
4,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $2,392,275,927 across 187 Biotechnology names. MDGL ranks #2 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APLS |
Apellis Pharmaceuticals, Inc.
|
4,183,918 | $168,319,021 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
This page
|
225,510 | $118,047,719 | |
| 3 | CLDX |
Celldex Therapeutics, Inc.
|
3,229,939 | $102,453,665 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
846,801 | $73,646,282 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
424,750 | $71,791,245 | |
| 6 | ABVX |
Abivax S.A.
|
637,736 | $71,011,903 | |
| 7 | LEGN |
Legend Biotech Corp
|
3,886,017 | $70,298,047 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
358,634 | $67,799,757 |
All Filings in MDGL
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,565,003 | 4,900 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $2,355,615 | 4,500 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $118,047,719 | 225,510 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $73,628,157 | 126,435 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $2,911,700 | 5,000 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $3,086,402 | 5,300 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $18,911,927 | 41,233 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $33,555,815 | 110,877 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $21,814,807 | 65,860 | Shares | Defined | 2025-07-21 | |
| 2024-06-30 | $11,474,793 | 40,958 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $40,056,000 | 150,000 | Put | Defined | 2024-05-15 | |
| 2024-03-31 | $24,987,199 | 93,571 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $25,250,316 | 172,900 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $967,344 | 3,993 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $1,486,711 | 22,876 | Shares | Defined | 2022-11-14 | |
| 2021-09-30 | $2,401,679 | 30,100 | Shares | Defined | 2021-11-15 | |
| 2020-03-31 | $5,267,364 | 78,900 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||